Evaluation of risk stratification schemes for ischaemic stroke and bleeding in 182 678 patients with atrial fibrillation: the Swedish Atrial Fibrillation cohort study

Dabigatran versus warfarin in patients with atrial fibrillation

Connolly, S. J., Ezekowitz, M. D., Yusuf, S., Eikelboom, J., Oldgren, J., Parekh, A., Pogue, J., Reilly, P. A., Themeles, E., Varrone, J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0905561 · Cited by 11,215 · see citing works

Apixaban versus warfarin in patients with atrial fibrillation

Granger, C. B., Alexander, J. H., McMurray, J. J. V., Lopes, R. D., Hylek, E. M., Hanna, M., Al-Khalidi, H. R., Ansell, J., Atar, D., Avezum, A., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1107039 · Cited by 8,943 · see citing works

Refining Clinical Risk Stratification for Predicting Stroke and Thromboembolism in Atrial Fibrillation Using a Novel Risk Factor-Based Approach

Lip, G. Y. H., Nieuwlaat, R., Pisters, R., Lane, D. A., & Crijns, H. J. G. M. (2010) · Chest · doi:10.1378/chest.09-1584 · Cited by 6,879 · see citing works

Evaluating the added predictive ability of a new marker: From area under the ROC curve to reclassification and beyond

Pencina, M. J., D' Agostino, R. B., D' Agostino, R. B., & Vasan, R. S. (2008) · Statistics in Medicine · doi:10.1002/sim.2929 · Cited by 6,493 · see citing works

Guidelines for the management of atrial fibrillation

Authors/Task Force Members, Camm, A. J., Kirchhof, P. F., Lip, G. Y. H., Schotten, U., Savelieva, I., Ernst, S., Gelder, I. C. V., Al‐Attar, N., Hindricks, G., et al. (2010) · European Heart Journal · doi:10.1093/eurheartj/ehq278 · Cited by 5,875 · see citing works

Validation of Clinical Classification Schemes for Predicting Stroke: Results From the National Registry of Atrial Fibrillation

Gage, B. F., Waterman, A. D., Shannon, W., Boechler, M., Rich, M. W., & Radford, M. J. (2001) · JAMA · doi:10.1001/jama.285.22.2864 · Cited by 4,832 · see citing works

A Novel User-Friendly Score (HAS-BLED) To Assess 1-Year Risk of Major Bleeding in Patients With Atrial Fibrillation

Pisters, R., Lane, D. A., Nieuwlaat, R., de Vos, C. B., Crijns, H. J. G. M., & Lip, G. Y. H. (2010) · CHEST Journal · doi:10.1378/chest.10-0134 · Cited by 4,517 · see citing works

Effect of clopidogrel added to aspirin in patients with atrial fibrillation

The ACTIVE Investigators (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0901301 · Cited by 2,102 · see citing works

Comments on ‘Evaluating the added predictive ability of a new marker: From area under the ROC curve to reclassification and beyond’ by M. J. Pencina, R. B. D'Agostino Sr, R. B. D'Agostino Jr, R. S. Vasan, Statistics in Medicine (DOI: 10.1002/sim.2929)

Greenland, P. (2007) · Statistics in Medicine · doi:10.1002/sim.2976 · Cited by 1,300 · see citing works

Comparative Validation of a Novel Risk Score for Predicting Bleeding Risk in Anticoagulated Patients With Atrial Fibrillation

Lip, G. Y. H., Frison, L., Halperin, J. L., & Lane, D. A. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.09.024 · Cited by 1,077 · see citing works

Major Hemorrhage and Tolerability of Warfarin in the First Year of Therapy Among Elderly Patients With Atrial Fibrillation

Hylek, E. M., Evans‐Molina, C., Shea, C., Henault, L. E., & Regan, S. (2007) · Circulation · doi:10.1161/circulationaha.106.653048 · Cited by 1,054 · see citing works

Clinical classification schemes for predicting hemorrhage: results from the National Registry of Atrial Fibrillation (NRAF)

Gage, B. F., Yan, Y., Milligan, P. E., Waterman, A. D., Culverhouse, R., Rich, M. W., & Radford, M. J. (2006) · American Heart Journal · doi:10.1016/j.ahj.2005.04.017 · Cited by 1,008 · see citing works

Risk of bleeding with single, dual, or triple therapy with warfarin, aspirin, and clopidogrel in patients with atrial fibrillation

Hansen, M. L., Sørensen, R., Clausen, M. T., Fog-Petersen, M. L., Raunsø, J., Gadsbøll, N., Gislason, G. H., Folke, F., Andersen, S. S., Schramm, T. K., et al. (2010) · Archives of Internal Medicine · doi:10.1001/archinternmed.2010.271 · Cited by 855 · see citing works

A Risk Score for Predicting Stroke or Death in Individuals With New-Onset Atrial Fibrillation in the Community

Wang, T. J., Massaro, J. M., Levy, D. A., Vasan, R. S., Wolf, P. A., D’Agostino, R. B., Larson, M. G., Kannel, W. B., & Benjamin, E. J. (2003) · JAMA · doi:10.1001/jama.290.8.1049 · Cited by 779 · see citing works

Prevalence of left-ventricular systolic dysfunction and heart failure in the Echocardiographic Heart of England Screening study: a population based study

Davies, M., Hobbs, F., Davis, R., Kenkre, J., Roalfe, A., Hare, R., Wosornu, D., & Lancashire, R. (2001) · The Lancet · doi:10.1016/s0140-6736(01)05620-3 · Cited by 657 · see citing works

ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation–executive summary

Authors Task Force Members, Fuster, V., Rydén, L., Cannom, D. S., Crijns, H. J. G. M., Curtis, A. B., Ellenbogen, K. A., Halperin, J. L., Heuzey, J. L., Kay, G. N., et al. (2006) · European Heart Journal · doi:10.1093/eurheartj/ehl176 · Cited by 645 · see citing works

Atrial fibrillation in acute myocardial infarction: a systematic review of the incidence, clinical features and prognostic implications

Schmitt, J., Duray, G. Z., Gersh, B. J., & Hohnloser, S. H. (2008) · European Heart Journal · doi:10.1093/eurheartj/ehn579 · Cited by 613 · see citing works

Independent predictors of stroke in patients with atrial fibrillation

The Stroke Risk in Atrial Fibrillation Working Group (2007) · Neurology · doi:10.1212/01.wnl.0000267275.68538.8d · Cited by 545 · see citing works

Choosing Antithrombotic Therapy for Elderly Patients With Atrial Fibrillation Who Are at Risk for Falls

Man‐Son‐Hing, M., Nichol, G., Lau, A., & Laupacis, A. (1999) · Archives of Internal Medicine · doi:10.1001/archinte.159.7.677 · Cited by 537 · see citing works

Advanced Age, Anticoagulation Intensity, and Risk for Intracranial Hemorrhage among Patients Taking Warfarin for Atrial Fibrillation

Fang, M. C., Chang, Y., Hylek, E. M., Rosand, J. M., Greenberg, S. M., Go, A. S., & Singer, D. E. (2004) · Annals of Internal Medicine · doi:10.7326/0003-4819-141-10-200411160-00005 · Cited by 532 · see citing works

Factors Associated With Ischemic Stroke During Aspirin Therapy in Atrial Fibrillation

Hart, R. G., Pearce, L. A., McBride, R., Rothbart, R. M., & ASINGER, R. W. (1999) · Stroke · doi:10.1161/01.str.30.6.1223 · Cited by 532 · see citing works

Transesophageal Echocardiographic Correlates of Thromboembolism in High-Risk Patients with Nonvalvular Atrial Fibrillation

(1998) · Annals of Internal Medicine · doi:10.7326/0003-4819-128-8-199804150-00005 · Cited by 510 · see citing works

Identifying Patients at High Risk for Stroke Despite Anticoagulation

Lip, G. Y. H., Frison, L., Halperin, J. L., & Lane, D. A. (2010) · Stroke · doi:10.1161/strokeaha.110.590257 · Cited by 493 · see citing works

Warfarin use associates with increased risk for stroke in hemodialysis patients with atrial fibrillation

Chan, K. E., Lazarus, J. M., Thadhani, R., & Hakim, R. M. (2009) · Journal of the American Society of Nephrology · doi:10.1681/asn.2009030319 · Cited by 431 · see citing works

The Validity of a Diagnosis of Heart Failure in a Hospital Discharge Register

Ingelsson, E., Ärnlöv, J., Sundström, J., & Lind, L. (2005) · European Journal of Heart Failure · doi:10.1016/j.ejheart.2004.12.007 · Cited by 412 · see citing works

Stroke and thromboembolism in atrial fibrillation: a systematic review of stroke risk factors, risk stratification schema and cost effectiveness data

Hughes, M., Lip, G. Y. H., & on behalf of the Guideline Development Group for the NICE national clinical guideline for management of atrial fibrillation in primary and secondary care (2008) · Thrombosis and Haemostasis · doi:10.1160/th07-08-0508 · Cited by 371 · see citing works

Comparison of Risk Stratification Schemes to Predict Thromboembolism in People With Nonvalvular Atrial Fibrillation

Fang, M. C., Go, A. S., Chang, Y., Borowsky, L. H., Pomernacki, N. K., & Singer, D. E. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.09.065 · Cited by 311 · see citing works

Echocardiographic Predictors of Stroke in Patients With Atrial Fibrillation

Atrial Fibrillation Investigators: Atrial Fibrillation, A. (1998) · Archives of Internal Medicine · doi:10.1001/archinte.158.12.1316 · Cited by 302 · see citing works

Moving the Tipping Point

Eckman, M. H., Singer, D. E., Rosand, J. M., & Greenberg, S. M. (2010) · Circulation Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.110.958108 · Cited by 276 · see citing works

A comparison of risk stratification schemes for stroke in 79 884 atrial fibrillation patients in general practice

van Staa, T. P., Setakis, E., Tanna, G. L. D., Lane, D. A., & Lip, G. Y. H. (2010) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2010.04085.x · Cited by 273 · see citing works

Anticoagulation control in Sweden: reports of time in therapeutic range, major bleeding, and thrombo-embolic complications from the national quality registry AuriculA

Wieloch, M., Själander, A., Frykman, V., Rosenqvist, M., Eriksson, N., & Svensson, P. J. (2011) · European Heart Journal · doi:10.1093/eurheartj/ehr134 · Cited by 261 · see citing works

Silent Cerebral Infarction in Patients With Nonrheumatic Atrial Fibrillation

Ezekowitz, M. D., James, K. E., Nazarian, S. M., Davenport, J., Broderick, J. P., Gupta, S. R., Thadani, V. M., Meyer, M., & Bridgers, S. L. (1995) · Circulation · doi:10.1161/01.cir.92.8.2178 · Cited by 250 · see citing works

Initiation and persistence of warfarin or aspirin in patients with chronic atrial fibrillation in general practice: do the appropriate patients receive stroke prophylaxis?

Gallagher, A. M., Rietbrock, S., Plumb, J., & van Staa, T. P. (2008) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2008.03059.x · Cited by 232 · see citing works

Bleeding risk in ‘real world’ patients with atrial fibrillation: comparison of two established bleeding prediction schemes in a nationwide cohort

Olesen, J. B., Lip, G. Y. H., Hansen, P. R., Lindhardsen, J., Ahlehoff, O., Andersson, C., Weeke, P. E., Hansen, M. L., Gislason, G., & Torp-Pedersen, C. T. (2011) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2011.04378.x · Cited by 201 · see citing works

Improving Stroke Risk Stratification in Atrial Fibrillation

Lip, G. Y. H., & Halperin, J. L. (2010) · The American Journal of Medicine · doi:10.1016/j.amjmed.2009.12.013 · Cited by 185 · see citing works

Stroke in thyrotoxicosis with atrial fibrillation.

Petersen, P., & Hansen, J. M. (1988) · Stroke · doi:10.1161/01.str.19.1.15 · Cited by 178 · see citing works

Revised A novel user-friendly score (HAS-BLED) to assess one-year risk of major bleeding in atrial fibrillation patients: The Euro Heart Survey

Pisters, R., Lane, D. A., Nieuwlaat, R., Crijns, H., & Lip, G. Y. H. (2012) · Cited by 171 · see citing works

Implications of the CHA2DS2-VASc and HAS-BLED Scores for Thromboprophylaxis in Atrial Fibrillation

Lip, G. Y. H. (2010) · The American Journal of Medicine · doi:10.1016/j.amjmed.2010.05.007 · Cited by 157 · see citing works

Increased Risk of Intracranial Hemorrhage when Aspirin Is Combined with Warfarin: A Meta-Analysis and Hypothesis

Hart, R. G., Benavente, O., & Pearce, L. A. (1999) · Cerebrovascular Diseases · doi:10.1159/000015958 · Cited by 149 · see citing works

Diastolic dysfunction and diastolic heart failure: diagnostic, prognostic and therapeutic aspects

Galderisi, M. (2005) · Cardiovascular Ultrasound · doi:10.1186/1476-7120-3-9 · Cited by 140 · see citing works

Trend in Mortality after Stroke with Atrial Fibrillation

Frost, L., Andersen, L. V., Vestergaard, P., Husted, S., & Mortensen, L. S. (2007) · The American Journal of Medicine · doi:10.1016/j.amjmed.2005.12.027 · Cited by 86 · see citing works

Stroke Risk Stratification in a “Real-World” Elderly Anticoagulated Atrial Fibrillation Population

Poli, D., Lip, G. Y. H., Antonucci, E., Grifoni, E., & Lane, D. A. (2010) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.2010.01858.x · Cited by 78 · see citing works

Warfarin in haemodialysis patients with atrial fibrillation: what benefit?

Yang, F., Chou, D. E., Schweitzer, P., & Hanon, S. (2010) · EP Europace · doi:10.1093/europace/euq387 · Cited by 64 · see citing works

Trends in Risk of Stroke in Patients with a Hospital Diagnosis of Nonvalvular Atrial Fibrillation: National Cohort Study in Denmark, 1980–2002

Frost, L., Andersen, L. V., Vestergaard, P., Husted, S., & Mortensen, L. S. (2006) · Neuroepidemiology · doi:10.1159/000092795 · Cited by 37 · see citing works

Apixaban versus warfarin in patients with atrial fibrillation

Deshpande, N. V. (2012) · Indian Heart Journal · doi:10.1016/s0019-4832(12)60030-3 · Cited by 36 · see citing works

Chronic renal disease and stroke in atrial fibrillation: balancing the prevention of thromboembolism and bleeding risk

Lip, G. Y. H. (2010) · EP Europace · doi:10.1093/europace/euq427 · Cited by 29 · see citing works

Time trends in the incidence of and mortality from acute myocardial infarction in Swedish women.

Hammar, N., Ahlbom, A., Sandberg, E., & Alfredsson, L. S. (1996) · PubMed · Cited by 5 · see citing works

1. In all likelihood. Yudi Pawitan, Oxford University Press, Oxford, 2001. No. of pages: xiii + 515. Price: £40.00. ISBN: 0-19-850765-8

Azzalini, A. (2004) · Statistics in Medicine · doi:10.1002/sim.1734 · Cited by 4 · see citing works

2018 ESC/ESH Guidelines for the management of arterial hypertension

Williams, B., Mancia, G., Spiering, W., Agabiti Rosei, E., Azizi, M., Burnier, M., Clement, D. L., Coca, A., de Simone, G., Dominiczak, A., et al. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehy339 · Cited by 10,286 · see citing works

2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS).

Hindricks, G., Potpara, T., Dagres, N., Arbelo, E., Bax, J., Blomström-Lundqvist, C., Boriani, G., Castellá, M., Dan, G., Dilaveris, P. E., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehaa612 · Cited by 2,605 · see citing works

2018 ESC/EACTS guidelines on myocardial revascularization

Neumann, F.-J., Sousa-Uva, M., Ahlsson, A., Alfonso, F., Banning, A. P., Benedetto, U., Byrne, R. A., Collet, J.-P., Falk, V., Head, S. J., et al. (2019) · European Heart Journal · doi:10.1093/eurheartj/ehy394 · Cited by 7,167 · see citing works

2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS

Kirchhof, P. F., Benussi, S., Kotecha, D., Ahlsson, A., Atar, D., Casadei, B., Castellà, M., Diener, H., Heidbüchel, H., Hendriks, J., et al. (2016) · EP Europace · doi:10.1093/europace/euw295 · Cited by 6,438 · see citing works

2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS

Kirchhof, P., Benussi, S., Kotecha, D., Ahlsson, A., Atar, D., Casadei, B., Castella, M., Diener, H.-C., Heidbuchel, H., Hendriks, J., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw210 · Cited by 6,418 · see citing works

2012 focused update of the ESC Guidelines for the management of atrial fibrillation

Authors Task Force Members, Camm, A. J., Lip, G. Y. H., Caterina, R. D., Savelieva, I., Atar, D., Hohnloser, S. H., Hindricks, G., Kirchhof, P. F., Bax, J. J., et al. (2012) · EP Europace · doi:10.1093/europace/eus305 · Cited by 3,814 · see citing works

2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)

Gelder, I. C. V., Rienstra, M., Bunting, K. V., Casado-Arroyo, R., Caso, V., Crijns, H. J. G. M., Potter, T. J. R. D., Dwight, J., Guasti, L., Hanke, T., et al. (2024) · European Heart Journal · doi:10.1093/eurheartj/ehae176 · Cited by 3,338 · see citing works

2012 focused update of the ESC Guidelines for the management of atrial fibrillation

Authors Task Force Members, Camm, A. J., Lip, G. Y. H., Caterina, R. D., Savelieva, I., Atar, D., Hohnloser, S. H., Hindricks, G., Kirchhof, P. F., Bax, J. J., et al. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs253 · Cited by 2,898 · see citing works

2018 ESC/ESH Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension

Williams, B., Mancia, G., Spiering, W., Agabiti Rosei, E., Azizi, M., Burnier, M., Clement, D. L., Coca, A., de Simone, G., Dominiczak, A., et al. (2018) · Journal of Hypertension · doi:10.1097/hjh.0000000000001940 · Cited by 2,885 · see citing works

2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS

Kirchhof, P., Benussi, S., Kotecha, D., Ahlsson, A., Atar, D., Casadei, B., Castella, M., Diener, H.-C., Heidbuchel, H., Hendriks, J., et al. (2016) · European Journal of Cardio-Thoracic Surgery · doi:10.1093/ejcts/ezw313 · Cited by 1,403 · see citing works

2018 ESC/EACTS Guidelines on myocardial revascularization

Neumann, F., Sousa‐Uva, M., Ahlsson, A., Alfonso, F., BANNING, A. P., Benedetto, U., Byrne, R. A., Collet, J., Falk, V., Head, S. J., et al. (2019) · EuroIntervention · doi:10.4244/eijy19m01_01 · Cited by 1,268 · see citing works

Updated European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist anticoagulants in patients with non-valvular atrial fibrillation

Heidbüchel, H., Verhamme, P. B., Alings, M., Antz, M., Diener, H., Hacke, W., Oldgren, J., Sinnaeve, P., Camm, A. J., & Kirchhof, P. F. (2015) · EP Europace · doi:10.1093/europace/euv309 · Cited by 1,114 · see citing works

5-Year Outcomes After Left Atrial Appendage Closure

Reddy, V. Y., Doshi, S. K., Kar, S., Gibson, D. N., Price, M. J., Huber, K., Horton, R., Buchbinder, M., Neužil, P., Gordon, N. T., et al. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.10.021 · Cited by 1,039 · see citing works

2018 ESC/EACTS Guidelines on myocardial revascularization

Sousa-Uva, M., Neumann, F., Ahlsson, A., Alfonso, F., BANNING, A. P., Benedetto, U., Byrne, R. A., Collet, J., Falk, V., Head, S. J., et al. (2018) · European Journal of Cardio-Thoracic Surgery · doi:10.1093/ejcts/ezy289 · Cited by 1,015 · see citing works

Antithrombotic Therapy for Atrial Fibrillation

Lip, G. Y. H., Banerjee, A., Boriani, G., Chiang, C. E., Fargo, R. A., Freedman, B., Lane, D. A., Ruff, C. T., Turakhia, M. P., Werring, D. J., et al. (2018) · CHEST Journal · doi:10.1016/j.chest.2018.07.040 · Cited by 952 · see citing works

European Heart Rhythm Association Practical Guide on the use of new oral anticoagulants in patients with non-valvular atrial fibrillation

Heidbuchel, H., Verhamme, P., Alings, M., Antz, M., Hacke, W., Oldgren, J., Sinnaeve, P., Camm, A. J., & Kirchhof, P. (2013) · Europace · doi:10.1093/europace/eut083 · Cited by 792 · see citing works

The 2020 Canadian Cardiovascular Society/Canadian Heart Rhythm Society Comprehensive Guidelines for the Management of Atrial Fibrillation

Andrade, J. G., Aguilar, M., Atzema, C. L., Bell, A., Cairns, J. A., Cheung, C. C., Cox, J. L., Dorian, P., Gladstone, D. J., Healey, J. S., et al. (2020) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2020.09.001 · Cited by 568 · see citing works

The novel biomarker-based ABC (age, biomarkers, clinical history)-bleeding risk score for patients with atrial fibrillation: a derivation and validation study

Hijazi, Z., Oldgren, J., Lindbäck, J., Alexander, J. H., Connolly, S. J., Eikelboom, J. W., Ezekowitz, M. D., Held, C., Hylek, E. M., Lopes, R. D., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)00741-8 · Cited by 490 · see citing works

The value of the CHA2DS2-VASc score for refining stroke risk stratification in patients with atrial fibrillation with a CHADS2 score 0–1: A nationwide cohort study

Olesen, J. B., Torp-Pedersen, C. T., Hansen, M. L., & Lip, G. Y. H. (2012) · Thrombosis and Haemostasis · doi:10.1160/th12-03-0175 · Cited by 484 · see citing works

Device-Related Thrombus After Left Atrial Appendage Closure

Dukkipati, S. R., Kar, S., Holmes, D. R., Doshi, S. K., Swarup, V., Gibson, D. N., Maini, B. S., Gordon, N. T., Main, M. L., & Reddy, V. Y. (2018) · Circulation · doi:10.1161/circulationaha.118.035090 · Cited by 455 · see citing works

2017 ACC Expert Consensus Decision Pathway for Periprocedural Management of Anticoagulation in Patients With Nonvalvular Atrial Fibrillation

Doherty, J. U., Gluckman, T. J., Hucker, W. J., Januzzi, J. L., Ortel, T. L., Saxonhouse, S. J., & Spinler, S. A. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.11.024 · Cited by 445 · see citing works

The ORBIT bleeding score: a simple bedside score to assess bleeding risk in atrial fibrillation

O'Brien, E. C., Simon, D. N., Thomas, L. E., Hylek, E. M., Gersh, B. J., Ansell, J., Kowey, P. R., Mahaffey, K. W., Chang, P., Fonarow, G. C., et al. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehv476 · Cited by 440 · see citing works

The ABC (age, biomarkers, clinical history) stroke risk score: a biomarker-based risk score for predicting stroke in atrial fibrillation

Hijazi, Z., Lindbäck, J., Alexander, J. H., Hanna, M., Held, C., Hylek, E. M., Lopes, R. D., Oldgren, J., Siegbahn, A., Stewart, R. A. H., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw054 · Cited by 437 · see citing works

Efficacy and safety of left atrial appendage closure with WATCHMAN in patients with or without contraindication to oral anticoagulation: 1-Year follow-up outcome data of the EWOLUTION trial

Boersma, L. V. A., Ince, H., Kische, S., Pokushalov, E., Schmitz, T., Schmidt, B., Gori, T., Meincke, F., Protopopov, A. V., Betts, T. R., et al. (2017) · Heart Rhythm · doi:10.1016/j.hrthm.2017.05.038 · Cited by 433 · see citing works

Anticoagulation with Edoxaban in Patients with Atrial High-Rate Episodes

Kirchhof, P. F., Toennis, T., Goette, A., Camm, A. J., Diener, H., Becher, N., Bertaglia, E., Lundqvist, C. B., Borlich, M., Brandes, A., et al. (2023) · New England Journal of Medicine · doi:10.1056/nejmoa2303062 · Cited by 442 · see citing works

EHRA Practical Guide on the use of new oral anticoagulants in patients with non-valvular atrial fibrillation: executive summary

Heidbüchel, H., Verhamme, P. B., Alings, M., Antz, M., Hacke, W., Oldgren, J., Sinnaeve, P., Camm, A. J., & Kirchhof, P. F. (2013) · European Heart Journal · doi:10.1093/eurheartj/eht134 · Cited by 404 · see citing works

2020 Clinical practice guidelines for Chronic heart failure

Russian Society of Cardiology (2020) · Russian Journal of Cardiology · doi:10.15829/1560-4071-2020-4083 · Cited by 529 · see citing works

Use of the CHA 2 DS 2 -VASc and HAS-BLED Scores to Aid Decision Making for Thromboprophylaxis in Nonvalvular Atrial Fibrillation

Lane, D. A., & Lip, G. Y. H. (2012) · Circulation · doi:10.1161/circulationaha.111.060061 · Cited by 389 · see citing works

Warfarin Use and the Risk for Stroke and Bleeding in Patients With Atrial Fibrillation Undergoing Dialysis

Shah, M., Tsadok, M. A., Jackevicius, C. A., Essebag, V., Eisenberg, M. J., Rahme, E., Humphries, K. H., Tu, J. V., Behlouli, H., Guo, H., et al. (2014) · Circulation · doi:10.1161/circulationaha.113.004777 · Cited by 336 · see citing works

EHRA/EAPCI expert consensus statement on catheter-based left atrial appendage occlusion

Meier, B., Blaauw, Y., Khattab, A. A., Lewalter, T., Sievert, H., Tondo, C., Glikson, M., ESC Scientific Document Group, Lip, G. Y. H., López-Mínguez, J. R., et al. (2014) · EP Europace · doi:10.1093/europace/euu174 · Cited by 327 · see citing works

A prospective survey in European Society of Cardiology member countries of atrial fibrillation management: baseline results of EURObservational Research Programme Atrial Fibrillation (EORP-AF) Pilot General Registry

Lip, G. Y. H., Laroche, C., Dan, G., Santini, M., Kalarus, Z. F., Rasmussen, L. H., Oliveira, M., Mairesse, G. H., Crijns, H. J. G. M., Simantirakis, E., et al. (2013) · EP Europace · doi:10.1093/europace/eut373 · Cited by 323 · see citing works

Stroke Prevention in Atrial Fibrillation

Lip, G. Y. H., & Lane, D. A. (2015) · JAMA · doi:10.1001/jama.2015.4369 · Cited by 327 · see citing works

Sex differences in cardiac arrhythmia: a consensus document of the European Heart Rhythm Association, endorsed by the Heart Rhythm Society and Asia Pacific Heart Rhythm Society

Linde, C. M., Bongiorni, M. G., Birgersdotter-Green, U. M., Curtis, A. B., Deisenhofer, I., Furokawa, T., Gillis, A. M., Haugaa, K. H., Lip, G. Y. H., Gelder, I. C. V., et al. (2018) · EP Europace · doi:10.1093/europace/euy067 · Cited by 298 · see citing works

Perioperative/Postoperative Atrial Fibrillation and Risk of Subsequent Stroke and/or Mortality

Lin, M.-H., Kamel, H., Singer, D. E., Wu, Y., Lee, M., & Ovbiagele, B. I. (2019) · Stroke · doi:10.1161/strokeaha.118.023921 · Cited by 298 · see citing works

Subclinical and Overt Thyroid Dysfunction and Risk of All-Cause Mortality and Cardiovascular Events: A Large Population Study

Selmer, C., Olesen, J. B., Hansen, M. L., von Kappelgaard, L. M., Madsen, J. C., Hansen, P. R., Pedersen, O. D., Faber, J., Torp-Pedersen, C., & Gislason, G. H. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-4184 · Cited by 288 · see citing works

Impact of Renal Function on Outcomes With Edoxaban in the ENGAGE AF-TIMI 48 Trial

Bohula, E. A., Giugliano, R. P., Ruff, C. T., Kuder, J., Murphy, S. A., Antman, E. M., & D, E. B. M. (2016) · Circulation · doi:10.1161/circulationaha.116.022361 · Cited by 291 · see citing works

Evaluating Real-World Clinical Outcomes in Atrial Fibrillation Patients Receiving the WATCHMAN Left Atrial Appendage Closure Technology

Boersma, L. V. A., Ince, H., Kische, S., Pokushalov, E., Schmitz, T., Schmidt, B., Gori, T., Meincke, F., Protopopov, A. V., Betts, T. R., et al. (2019) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.118.006841 · Cited by 290 · see citing works

Two-year outcomes of patients with newly diagnosed atrial fibrillation: results from GARFIELD-AF

Bassand, J., Accetta, G., Camm, A. J., Cools, F. J. S., Fitzmaurice, D. A., Fox, K. A. A., Goldhaber, S. Z., Goto, S., Haas, S. K., Hacke, W., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw233 · Cited by 288 · see citing works

Differences in Clinical and Functional Outcomes of Atrial Fibrillation in Women and Men

Piccini, J. P., Simon, D. N., Steinberg, B. A., Thomas, L. E., Allen, L. A., Fonarow, G. C., Gersh, B. J., Hylek, E. M., Kowey, P. R., Reiffel, J. A., et al. (2016) · JAMA Cardiology · doi:10.1001/jamacardio.2016.0529 · Cited by 274 · see citing works

Percutaneous Left Atrial Appendage Closure With the AMPLATZER Cardiac Plug Device in Patients With Nonvalvular Atrial Fibrillation and Contraindications to Anticoagulation Therapy

Ureña, M., Rodés‐Cabau, J., Freixa, X., Saw, J., Webb, J. G., Freeman, M., Horlick, E. M., Osten, M., Chan, A. W., Marquis, J.-F., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.02.089 · Cited by 270 · see citing works

Restarting Anticoagulant Treatment After Intracranial Hemorrhage in Patients With Atrial Fibrillation and the Impact on Recurrent Stroke, Mortality, and Bleeding: A Nationwide Cohort Study

Nielsen, P. B., Larsen, T. B., Skjøth, F., Gorst-Rasmussen, A., Rasmussen, L. H., & Lip, G. Y. H. (2015) · Circulation · doi:10.1161/circulationaha.115.015735 · Cited by 265 · see citing works

Hypertension and Atrial Fibrillation

Verdecchia, P., Angeli, F., & Reboldi, G. (2018) · Circulation Research · doi:10.1161/circresaha.117.311402 · Cited by 255 · see citing works

Cerebral microbleeds and intracranial haemorrhage risk in patients anticoagulated for atrial fibrillation after acute ischaemic stroke or transient ischaemic attack (CROMIS-2): a multicentre observational cohort study

Wilson, D., Ambler, G., Shakeshaft, C., Brown, M. M., Charidimou, A., Salman, R. A., Lip, G. Y. H., Cohen, H., Banerjee, G., Houlden, H., et al. (2018) · The Lancet Neurology · doi:10.1016/s1474-4422(18)30145-5 · Cited by 254 · see citing works

Prospective National Study of the Prevalence, Incidence, Management and Outcome of a Large Contemporary Cohort of Patients With Incident Non‐Valvular Atrial Fibrillation

Haim, M., Hoshen, M., Reges, O., Rabi, Y., Balicer, R. D., & Leibowitz, M. (2015) · Journal of the American Heart Association · doi:10.1161/jaha.114.001486 · Cited by 249 · see citing works

Postoperative Arrhythmias after Cardiac Surgery: Incidence, Risk Factors, and Therapeutic Management

Peretto, G., Durante, A., Limite, L. R., & Cianflone, D. (2014) · Cardiology Research and Practice · doi:10.1155/2014/615987 · Cited by 243 · see citing works

Apixaban for Patients With Atrial Fibrillation on Hemodialysis: A Multicenter Randomized Controlled Trial

Pokorney, S. D., Chertow, G. M., Al‐Khalidi, H. R., Gallup, D. S., Dignacco, P., Mussina, K., Bansal, N., Gadegbeku, C. A., Garcia, D. A., Merali, S. J., et al. (2022) · Circulation · doi:10.1161/circulationaha.121.054990 · Cited by 240 · see citing works

N-Terminal Pro–B-Type Natriuretic Peptide for Risk Assessment in Patients With Atrial Fibrillation

Hijazi, Z., Wallentin, L., Siegbahn, A., Andersson, U., Christersson, C., Ezekowitz, J., Gersh, B. J., Hanna, M., Hohnloser, S., Horowitz, J., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.11.082 · Cited by 231 · see citing works

Predicting thromboembolic and bleeding event risk in patients with non-valvular atrial fibrillation: a systematic review

Borre, E., Goode, A., Raitz, G., Shah, B., Lowenstern, A., Chatterjee, R., Sharan, L., Allen LaPointe, N., Yapa, R., Davis, J., et al. (2018) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1675400 · Cited by 229 · see citing works

Assessing bleeding risk in patients taking anticoagulants

Shoeb, M., & Fang, M. C. (2013) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-013-0899-7 · Cited by 228 · see citing works

2020 Clinical guidelines for Atrial fibrillation and atrial flutter

Arakelyan, M., Bockeria, L., Vasilieva, E., Golitsyn, S., Golukhova, E., Gorev, M., Davtyan, K., Drapkina, O., Kropacheva, E., Kuchinskaya, E. A., et al. (2021) · Russian Journal of Cardiology · doi:10.15829/1560-4071-2021-4594 · Cited by 11 · see citing works

The HAS‐BLED Score for Predicting Major Bleeding Risk in Anticoagulated Patients With Atrial Fibrillation: A Systematic Review and Meta‐analysis

Zhu, W., He, W., Guo, L., Wang, X., & Hong, K. (2015) · Clinical Cardiology · doi:10.1002/clc.22435 · Cited by 225 · see citing works

Effect of Long-term Continuous Cardiac Monitoring vs Usual Care on Detection of Atrial Fibrillation in Patients With Stroke Attributed to Large- or Small-Vessel Disease

Bernstein, R. A., Kamel, H., Granger, C. B., Piccini, J. P., Sethi, P. P., Katz, J. M., Vives, C. A., Ziegler, P., Franco, N. C., Schwamm, L. H., et al. (2021) · JAMA · doi:10.1001/jama.2021.6470 · Cited by 217 · see citing works

2024 Clinical practice guidelines for Chronic heart failure

Galyavich, A. S., Tereshchenko, S. N., Uskach, T. M., Ageev, F. T., Aronov, D. M., Arutyunov, G. P., Begrambekova, Y. L., Belenkov, Y. N., Boytsov, S. A., Bubnova, M. G., et al. (2024) · Russian Journal of Cardiology · doi:10.15829/1560-4071-2024-6162 · Cited by 251 · see citing works

Benefit of anticoagulation unlikely in patients with atrial fibrillation and a CHA2DS2-VASc score of 1

Friberg, L., Skeppholm, M., & Terént, A. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.10.052 · Cited by 207 · see citing works

Comparative Performance of ATRIA, CHADS2, and CHA2DS2-VASc Risk Scores Predicting Stroke in Patients With Atrial Fibrillation

van den Ham, H. A., Klungel, O. H., Singer, D. E., Leufkens, H. G. M., & van Staa, T. P. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.08.033 · Cited by 205 · see citing works

Oral anticoagulants for primary prevention, treatment and secondary prevention of venous thromboembolic disease, and for prevention of stroke in atrial fibrillation: systematic review, network meta-analysis and cost-effectiveness analysis

Sterne, J. A. C., Bodalia, P. N., Bryden, P. A., Davies, P. A., López-López, J. A., Okoli, G. N., Thom, H. H. Z., Caldwell, D. M., Dias, S., Eaton, D., et al. (2017) · Health Technology Assessment · doi:10.3310/hta21090 · Cited by 201 · see citing works

Medical Services Advisory Committee

Culyer, A. J. (2014) · Cited by 198 · see citing works

Predictive Value of the HAS-BLED and ATRIA Bleeding Scores for the Risk of Serious Bleeding in a “Real-World” Population With Atrial Fibrillation Receiving Anticoagulant Therapy

Roldán, V., Marín, F. R., Fernández, H., Manzano‐Fernández, S., Gallego, P., Valdés, M., Vicente, V., & Lip, G. Y. H. (2012) · CHEST Journal · doi:10.1378/chest.12-0608 · Cited by 193 · see citing works

2017 consensus of the Asia Pacific Heart Rhythm Society on stroke prevention in atrial fibrillation

Chiang, C., Okumura, K., Zhang, S., Chao, T., Siu, C., Lim, T. W., Saxena, A., Takahashi, Y., & Teo, W. S. (2017) · Journal of Arrhythmia · doi:10.1016/j.joa.2017.05.004 · Cited by 198 · see citing works

An Update on the Prognosis of Patients With Atrial Fibrillation

McManus, D. D., Rienstra, M., & Benjamin, E. J. (2012) · Circulation · doi:10.1161/circulationaha.112.129759 · Cited by 178 · see citing works

Long-Term Safety and Efficacy in Continued Access Left Atrial Appendage Closure Registries

Holmes, D. R., Reddy, V. Y., Gordon, N. T., DeLurgio, D. B., Doshi, S. K., Desai, A. J., Stone, J. E., & Kar, S. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.09.064 · Cited by 173 · see citing works

Left atrial appendage occlusion with the Amplatzer™ Amulet™ device: full results of the prospective global observational study

Hildick‐Smith, D., Landmesser, U., Camm, A. J., Diener, H., Paul, V., Schmidt, B., Settergren, M., Teíger, E., Nielsen‐Kudsk, J. E., & Tondo, C. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehaa169 · Cited by 171 · see citing works

Prediction of stroke or TIA in patients without atrial fibrillation using CHADS2 and CHA2DS2-VASc scores

Mitchell, L. B., Southern, D. A., Galbraith, D., Ghali, W. A., Knudtson, M. L., & Wilton, S. B. (2014) · Heart · doi:10.1136/heartjnl-2013-305303 · Cited by 161 · see citing works

Left Ventricular Systolic Dysfunction, Heart Failure, and the Risk of Stroke and Systemic Embolism in Patients With Atrial Fibrillation

McMurray, J. J. V., Ezekowitz, J. A., Lewis, B. S., Gersh, B. J., van Diepen, S., Amerena, J. V., Bartúnek, J., Commerford, P., Oh, B., Harjola, V., et al. (2013) · Circulation Heart Failure · doi:10.1161/circheartfailure.112.000143 · Cited by 160 · see citing works

Stroke and bleeding risk assessment in atrial fibrillation: when, how, and why?

Lip, G. Y. H. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs435 · Cited by 159 · see citing works

Effectiveness and Safety of Dabigatran and Warfarin in Real‐World US Patients With Non‐Valvular Atrial Fibrillation: A Retrospective Cohort Study

Lauffenburger, J. C., Farley, J. F., Gehi, A. K., Rhoney, D. H., Brookhart, M. A., & Fang, G. (2015) · Journal of the American Heart Association · doi:10.1161/jaha.115.001798 · Cited by 158 · see citing works

‘Real-World’ Antithrombotic Treatment in Atrial Fibrillation: The EORP-AF Pilot Survey

Lip, G. Y. H., Laroche, C., Dan, G., Santini, M., Kalarus, Z. F., Rasmussen, L. H., Ioachim, P. M., Țica, O., Boriani, G., Cimaglia, P., et al. (2014) · The American Journal of Medicine · doi:10.1016/j.amjmed.2013.12.022 · Cited by 156 · see citing works

Cost-effectiveness of mass screening for untreated atrial fibrillation using intermittent ECG recording

Aronsson, M., Svennberg, E., Rosenqvist, M., Engdahl, J., Al-Khalili, F., Friberg, L., Frykman-Kull, V., & Levin, L.-Å. (2015) · Europace · doi:10.1093/europace/euv083 · Cited by 154 · see citing works

Novel Risk Markers and Risk Assessments for Cardiovascular Disease

Thomas, M. R., & Lip, G. Y. H. (2017) · Circulation Research · doi:10.1161/circresaha.116.309955 · Cited by 154 · see citing works

Improved risk stratification of patients with atrial fibrillation: an integrated GARFIELD-AF tool for the prediction of mortality, stroke and bleed in patients with and without anticoagulation

Fox, K. A. A., Lucas, J. E., Pieper, K. S., Bassand, J., Camm, A. J., Fitzmaurice, D. A., Goldhaber, S. Z., Goto, S., Haas, S. K., Hacke, W., et al. (2017) · BMJ Open · doi:10.1136/bmjopen-2017-017157 · Cited by 152 · see citing works

Atrial Fibrillation and Hypertension

Dzeshka, M. S., Shantsila, A., Shantsila, E., & Lip, G. Y. H. (2017) · Hypertension · doi:10.1161/hypertensionaha.117.08934 · Cited by 148 · see citing works

Atrial Fibrillation and Thromboembolism in Patients With Chronic Kidney Disease

Lau, Y. C., Proietti, M., Guiducci, E., Blann, A. D., & Lip, G. Y. H. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.06.057 · Cited by 144 · see citing works

Prevention of stroke with the addition of ezetimibe to statin therapy in patients with acute coronary syndrome in IMPROVE-IT (Improved Reduction of Outcomes: Vytorin Efficacy International Trial)

Bohula, E. A., Wiviott, S. D., Giugliano, R. P., Blazing, M. A., Park, J.-G., Murphy, S. A., White, J. A., Mach, F., Van de Werf, F., Dalby, A. J., et al. (2017) · Circulation · doi:10.1161/circulationaha.117.029095 · Cited by 142 · see citing works

American College of Surgeons’ Guidelines for the Perioperative Management of Antithrombotic Medication

Hornor, M. A., Duane, T. M., Ehlers, A. P., Jensen, E. H., Brown, P. S., Pohl, D., Costa, P., Ko, C. Y., & Laronga, C. (2018) · Journal of the American College of Surgeons · doi:10.1016/j.jamcollsurg.2018.08.183 · Cited by 143 · see citing works

Screening strategies for atrial fibrillation: a systematic review and cost-effectiveness analysis.

Welton, N., McAleenan, A., Thom, H., Davies, P., Hollingworth, W., Higgins, J., Okoli, G., Sterne, J., Feder, G., Eaton, D., et al. (2017) · Health Technology Assessment · doi:10.3310/hta21290 · Cited by 133 · see citing works

Impact of Peridevice Leak on 5-Year Outcomes After Left Atrial Appendage Closure

Dukkipati, S. R., Holmes, D. R., Doshi, S. K., Kar, S., Singh, S. M., Gibson, D. N., Price, M. J., Natale, A., Mansour, M., Sievert, H., et al. (2022) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2022.04.062 · Cited by 140 · see citing works

2016 Guidelines of the Taiwan Heart Rhythm Society and the Taiwan Society of Cardiology for the management of atrial fibrillation

Chiang, C., Wu, T.-J., Ueng, K.-C., Chao, T., Chang, K., Wang, C.-C., Lin, Y., Yin, W., Kuo, J., Lin, W., et al. (2016) · Journal of the Formosan Medical Association · doi:10.1016/j.jfma.2016.10.005 · Cited by 138 · see citing works

Female sex as a risk factor for stroke in atrial fibrillation: a nationwide cohort study

MIKKELSEN, A. P., LINDHARDSEN, J., LIP, G. Y. H., GISLASON, G. H., TORP‐PEDERSEN, C., & OLESEN, J. B. (2012) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2012.04853.x · Cited by 137 · see citing works

Atrial Fibrillation and Ventricular Arrhythmias

Gillis, A. M. (2017) · Circulation · doi:10.1161/circulationaha.116.025312 · Cited by 132 · see citing works

CHADS2 versus CHA2DS2-VASc score in assessing the stroke and thromboembolism risk stratification in patients with atrial fibrillation: a systematic review and meta-analysis.

Chen, J., Zhang, A., Lu, H., Guo, J., Wang, F., & Li, Z. (2013) · Europe PMC (PubMed Central) · doi:10.3969/j.issn.1671-5411.2013.03.004 · Cited by 130 · see citing works

New‐Onset Atrial Fibrillation After Coronary Artery Bypass Grafting and Long‐Term Outcome: A Population‐Based Nationwide Study From the SWEDEHEART Registry

Taha, A., Nielsen, S. J., Bergfeldt, L., Ahlsson, A., Friberg, L., Björck, S., Franzén, S., & Jeppsson, A. (2020) · Journal of the American Heart Association · doi:10.1161/jaha.120.017966 · Cited by 132 · see citing works

JCS/JHRS 2020 Guideline on Pharmacotherapy of Cardiac Arrhythmias

Ono, K., Iwasaki, Y., Akao, M., Ikeda, T., Ishii, K., Inden, Y., Kusano, K., Kobayashi, Y., Koretsune, Y., Sasano, T., et al. (2022) · Circulation Journal · doi:10.1253/circj.cj-20-1212 · Cited by 132 · see citing works

Optimal Timing of Anticoagulant Treatment After Intracerebral Hemorrhage in Patients With Atrial Fibrillation

Pennlert, J., Overholser, R., Asplund, K., Carlberg, B., Rompaye, B. V., Wiklund, P.-G., & Eriksson, M. (2016) · Stroke · doi:10.1161/strokeaha.116.014643 · Cited by 130 · see citing works

Atrial fibrillation and stroke

Choi, S. E., Sagris, D., Hill, A. M., Lip, G. Y. H., & Abdul‐Rahim, A. H. (2022) · Expert Review of Cardiovascular Therapy · doi:10.1080/14779072.2023.2160319 · Cited by 136 · see citing works

Wide Variation in Reported Rates of Stroke Across Cohorts of Patients With Atrial Fibrillation

Quinn, G. R., Severdija, O. N., Chang, Y., & Singer, D. E. (2016) · Circulation · doi:10.1161/circulationaha.116.024057 · Cited by 128 · see citing works

European Heart Rhythm Association (EHRA)/European Association of Cardiovascular Prevention and Rehabilitation (EACPR) position paper on how to prevent atrial fibrillation endorsed by the Heart Rhythm Society (HRS) and Asia Pacific Heart Rhythm Society (APHRS)

Görenek, B., Pelliccia, A., Benjamin, E. J., Boriani, G., Crijns, H. J. G. M., Fogel, R. I., Gelder, I. C. V., Halle, M., Kudaiberdieva, G., Lane, D. A., et al. (2016) · EP Europace · doi:10.1093/europace/euw242 · Cited by 128 · see citing works

Use of oral anticoagulants in patients with atrial fibrillation and renal dysfunction

Potpara, T., Ferro, C. J., & Lip, G. Y. H. (2018) · Nature Reviews Nephrology · doi:10.1038/nrneph.2018.19 · Cited by 128 · see citing works

Atrial fibrillation in CLL patients treated with ibrutinib. An international retrospective study

Thompson, P. A., Lévy, V., Tam, C. S. L., Al‐Nawakil, C., Goudot, F., Quinquenel, A., Ysebaert, L., Michallet, A., Dilhuydy, M., Neste, E. V. D., et al. (2016) · British Journal of Haematology · doi:10.1111/bjh.14324 · Cited by 124 · see citing works

Half-Dose Direct Oral Anticoagulation Versus Standard Antithrombotic Therapy After Left Atrial Appendage Occlusion

Rocca, D. G. D., Magnocavallo, M., Biase, L. D., Mohanty, S., Trivedi, C. G., Tarantino, N. M., Gianni, C., Lavalle, C., Niekerk, C. J. V., Romero, J. E., et al. (2021) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2021.07.031 · Cited by 122 · see citing works

Differences in drug utilisation between men and women: a cross-sectional analysis of all dispensed drugs in Sweden

Loikas, D., Wettermark, B., von Euler, M., Bergman, U., & Schenck-Gustafsson, K. G. (2013) · BMJ Open · doi:10.1136/bmjopen-2012-002378 · Cited by 120 · see citing works

Oral Anticoagulant Prescription Trends, Profile Use, and Determinants of Adherence in Patients with Atrial Fibrillation

Perreault, S., de Denus, S., White‐Guay, B., Côté, R., Schnitzer, M. E., Dubé, M., Dorais, M., & Tardif, J. (2019) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.2350 · Cited by 120 · see citing works

Clinical Outcomes Associated With Left Atrial Appendage Occlusion Versus Direct Oral Anticoagulation in Atrial Fibrillation

Nielsen‐Kudsk, J. E., Korsholm, K., Damgaard, D., Valentin, J. B., Diener, H., Camm, A. J., & Johnsen, S. P. (2021) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2020.09.051 · Cited by 120 · see citing works

Frailty and Clinical Outcomes of Direct Oral Anticoagulants Versus Warfarin in Older Adults With Atrial Fibrillation

Kim, D. H., Pawar, A. M., Gagne, J. J., Bessette, L. G., Lee, H., Glynn, R. J., & Schneeweiß, S. (2021) · Annals of Internal Medicine · doi:10.7326/m20-7141 · Cited by 119 · see citing works

Effectiveness and Safety of Four Direct Oral Anticoagulants in Asian Patients With Nonvalvular Atrial Fibrillation

Chan, Y., Lee, H., See, L., Tu, H., Chao, T., Yeh, Y., Wu, L., Kuo, C.-T., Chang, S., & Lip, G. Y. H. (2019) · CHEST Journal · doi:10.1016/j.chest.2019.04.108 · Cited by 118 · see citing works

Left atrial function to identify patients with atrial fibrillation at high risk of stroke: new insights from a large registry

Leung, M., van Rosendael, P. J., Abou, R., Marsan, N. A., Leung, D. Y., Delgado, V., & Bax, J. J. (2017) · European Heart Journal · doi:10.1093/eurheartj/ehx736 · Cited by 116 · see citing works

Atrial Fibrillation and Ischemic Stroke: A Clinical Review

Migdady, I., Russman, A., & Buletko, A. B. (2021) · Seminars in Neurology · doi:10.1055/s-0041-1726332 · Cited by 121 · see citing works

Age Threshold for Increased Stroke Risk Among Patients With Atrial Fibrillation

Chao, T., Wang, K.-L., Liu, C.-J., Lin, Y., Chang, S., Lo, L., Hu, Y., Tuan, T., Chung, F., Liao, J., et al. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.07.026 · Cited by 114 · see citing works

Risk of stroke and intracranial hemorrhage in 9727 Chinese with atrial fibrillation in Hong Kong

Siu, C., Lip, G. Y. H., Lam, K., & Tse, H. (2014) · Heart Rhythm · doi:10.1016/j.hrthm.2014.04.021 · Cited by 114 · see citing works

Renal Impairment and Ischemic Stroke Risk Assessment in Patients With Atrial Fibrillation

Banerjee, A., Fauchier, L., Vourc’h, P., Andres, C. R., Taillandier, S., Halimi, J., & Lip, G. Y. H. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.02.035 · Cited by 112 · see citing works

Comparison of the ATRIA, CHADS 2 , and CHA 2 DS 2 -VASc stroke risk scores in predicting ischaemic stroke in a large Swedish cohort of patients with atrial fibrillation

Aspberg, S., Chang, Y., Atterman, A., Bottai, M., Go, A. S., & Singer, D. E. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw077 · Cited by 111 · see citing works

Stroke and Bleeding Risk Co-distribution in Real-world Patients with Atrial Fibrillation: The Euro Heart Survey

Marcucci, M., Lip, G. Y. H., Nieuwlaat, R., Pisters, R., Crijns, H. J. G. M., & Iorio, A. (2014) · The American Journal of Medicine · doi:10.1016/j.amjmed.2014.05.003 · Cited by 39 · see citing works

Stroke and Bleeding Risk in Atrial Fibrillation: Navigating the Alphabet Soup of Risk‐Score Acronyms (CHADS 2 , CHA 2 DS 2 ‐VASc, R 2 CHADS 2 , HAS‐BLED, ATRIA, and More)

Dzeshka, M. S., Lane, D. A., & Lip, G. Y. H. (2014) · Clinical Cardiology · doi:10.1002/clc.22294 · Cited by 57 · see citing works

The assessment of stroke and bleeding risk in atrial fibrillation: where are we now?

Pamukçu, B., Lane, D. A., & Lip, G. Y. H. (2010) · Expert Review of Cardiovascular Therapy · doi:10.1586/erc.10.153 · Cited by 2 · see citing works

Validation of risk stratification schemes for predicting stroke and thromboembolism in patients with atrial fibrillation: nationwide cohort study

Olesen, J. B., Lip, G. Y. H., Hansen, M. L., Hansen, P. R., Tolstrup, J. S., Lindhardsen, J., Selmer, C., Ahlehoff, O., Olsen, A.-M. S., Gislason, G. H., et al. (2011) · BMJ · doi:10.1136/bmj.d124 · Cited by 1,428 · see citing works

Usefulness of the CHA2DS2-VASc and HAS-BLED Scores in Predicting the Risk of Stroke Versus Intracranial Bleeding in Patients With Atrial Fibrillation (from the FibStroke Study)

Jaakkola, S., Kiviniemi, T., Nuotio, I. O., Hartikainen, J. E. K., Mustonen, P. E., Palomäki, A., Jaakkola, J., Ylitalo, A., Hartikainen, P. H., & Airaksinen, J. K. E. (2018) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2018.01.038 · Cited by 10 · see citing works